Drug offers hope in treating ocular melanoma

Video

Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.

The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.

Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.

Recent Videos
Dr. Mark Dunbar chats about his EyeCon 2024 presentation about diabetic eye care
Dr. Ferrucci summarizes his Vision Expo West presentations and shares clinical pearls for managing retinal cases.
Mohammad Rafieetary, OD, FAAO
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
© 2024 MJH Life Sciences

All rights reserved.